Tiperon

A control surface for an air vehicle (e.g., an aircraft, rocket, or missile) is useful for flight control at both subsonic and supersonic speeds. The control surface defines the outboardmost tip of a flight structure (e.g., a wing, tail or other stabilizer) of the air vehicle. Hence, the control surface is referred to as a `tiperon`. The tiperon has an approximately L-shaped configuration, and can be rotated relative to a fixed portion of the flight structure about a control axis. The respective surface areas of the tiperon sections forward and aft of the control axis are proportioned to place the subsonic center of pressure aft of the control axis to enhance aircraft control, and preferably also forward of the centroid of tiperon surface area. Also, the control surface sections forward and aft of the control axis are preferably mass-balanced, or at least nearly so, to enhance aircraft control at supersonic speeds. Either of the tiperon sections forward and aft of the control axis can be tapered to reduce the dependence of the moment exerted by air flow about the control axis, upon the tiperon's angle-of-attack. The tiperon also has enough surface area to control the air vehicle, even at low airspeeds. The invention is also directed to air vehicles incorporating one or more such control surfaces

Early vocational rehabilitation and psychological support for trauma patients to improve return to work (the ROWTATE trial): study protocol for an individually randomised controlled multicentre pragmatic trial

Background: Moderately severe or major trauma (injury severity score (ISS) > 8) is common, often resulting in physical and psychological problems and leading to difficulties in returning to work. Vocational rehabilitation (VR) can improve return to work/education in some injuries (e.g. traumatic brain and spinal cord injury), but evidence is lacking for other moderately severe or major trauma. Methods: ROWTATE is an individually randomised controlled multicentre pragmatic trial of early VR and psychological support in trauma patients. It includes an internal pilot, economic evaluation, a process evaluation and an implementation study. Participants will be screened for eligibility and recruited within 12 weeks of admission to eight major trauma centres in England. A total of 722 participants with ISS > 8 will be randomised 1:1 to VR and psychological support (where needed, following psychological screening) plus usual care or to usual care alone. The ROWTATE VR intervention will be provided within 2 weeks of study recruitment by occupational therapists and where needed, by clinical psychologists. It will be individually tailored and provided for ≤ 12 months, dependent on participant need. Baseline assessment will collect data on demographics, injury details, work/education status, cognitive impairment, anxiety, depression, post-traumatic distress, disability, recovery expectations, financial stress and health-related quality of life. Participants will be followed up by postal/telephone/online questionnaires at 3, 6 and 12 months post-randomisation. The primary objective is to establish whether the ROWTATE VR intervention plus usual care is more effective than usual care alone for improving participants’ self-reported return to work/education for at least 80% of pre-injury hours at 12 months post-randomisation. Secondary outcomes include other work outcomes (e.g. hours of work/education, time to return to work/education, sickness absence), depression, anxiety, post-traumatic distress, work self-efficacy, financial stress, purpose in life, health-related quality of life and healthcare/personal resource use. The process evaluation and implementation study will be described elsewhere. Discussion: This trial will provide robust evidence regarding a VR intervention for a major trauma population. Evidence of a clinically and cost-effective VR intervention will be important for commissioners and providers to enable adoption of VR services for this large and important group of patients within the NHS. Trial registration: ISRCTN: 43115471. Registered 27/07/2021

Polioencefalomalacia em bovinos nos estados de Mato Grosso do Sul e São Paulo Polioencephalomalacia in cattle in the states of Mato Grosso do Sul and São Paulo

Trinta focos de polioencefalomalacia (PEM) foram diagnosticados no período de agosto de 1993 a outubro de 1997. Vinte e nove focos ocorreram no estado de Mato Grosso do Sul (MS) e um no estado de São Paulo (SP). Foram afetados bovinos de 4 a 84 meses de idade. A morbidade dos rebanhos afetados variou de 0,02% a 14,28% e a letalidade de 42,5% a 100%. A doença não apresentou uma sazonalidade e ocorreu em vários municípios do MS. Em todos os focos estudados os animais afetados eram criados em regimes de criação extensiva, com exceção de um foco. Os sinais clínicos observados foram exclusivamente nervosos e a evolução dos casos variou de 12 horas a 4 dias. A maioria dos animais tratados com tiamina e dexametasona recuperou-se. Histologicamente, as lesões consistiam de necrose laminar do córtex cerebral. Adicionalmente em 2 casos observaram-se hemorragias submeningeanas e corticais, e em 9 casos presença de infiltrado de eosinófilos. A dosagem de sódio no líquor apresentou-se elevada em um caso. A etiologia da PEM não está esclarecida, porém em alguns casos a intoxicação por cloreto de sódio/privação de água pode estar envolvida na etiologia da enfermidade. A PEM representa 4,78% dos casos de enfermidades de bovinos diagnosticadas no Laboratório de Anatomia Patológica da UFMS. Com bases nos resultados, verifica-se a importância da enfermidade no diagnóstico diferencial de outras doenças com quadro clínico neurológico no MS, principalmente a raiva, a meningoencefalite por herpesvírus bovino tipo 5 (HVB-5) e o botulismo.<br>Thirty outbreaks of polioencephalomalacia (PEM) were diagnosed from August 1993 to October 1997. Twenty nine occurred in the state of Mato Grosso do Sul and one in São Paulo. The disease affected cattle from 4 months to 7 years of age. Morbidity rates ranged from 0.02% to 14.28% and case fatalities from 42.5 % to 100%. The disease was not seasonal. All outbreaks occurred in cattle grazing Brachiaria spp, except one affecting feedlot cattle. Only neurologic signs were observed, and the course of the disease varied from 12 hours to 4 days in untreated cattle. Most animals treated with thiamine and dexamethazone recovered. Moderate cerebral edema was observed at necropsy. Cell changes were characterized by laminar necrosis and gitter cells. In two cases moderate cortical and submeningeal hemorrhages were observed. Nine cases had perivascular and submeningeal infiltrations by eosinophils. Sodium ion concentration of the cerebrospinal fluid was elevated in one case. The cause of PEM in the region was not determined, but the results suggest that in some cases sodium chloride intoxication/water deprivation could play a role in the etiology of the disease. PEM represents 4.78% of cattle disease diagnosed at the Pathology Laboratory of the Federal University of Mato Grosso do Sul